Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

afinitor_logo

Blow for Scottish women as SMC rejects Afinitor for advanced breast cancer

October 12, 2015 Sales and Marketing SMC, advanced breast cancer

The Scottish Medicines Consortium (SMC) has announced that it will not recommend Novartis’s Afinitor (everolimus) for use in advanced breast …
News
zytiga

New cancer medicines approved in Scotland, available via NHS

October 12, 2015 Sales and Marketing Scottish Medicines Consortium, Zytiga, abiraterone acetate, prostate cancer

The Scottish Medicines Consortium (SMC) has today recommended Janssen’s Zytiga (abiraterone acetate) for use before chemotherapy in men with advanced …
News
abpi_logo

Health professionals back transparency of their dealings with pharma

October 12, 2015 Research and Development, Sales and Marketing ABPI, transparency

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …
News
FDA sign

Obama’s FDA nominee criticised for big pharma ties

October 12, 2015 Sales and Marketing Bernie Sanders, Dr Robert Califf, FDA

Democratic presidential nomination candidate Senator Bernie Sanders has criticised President Obama’s choice for the next FDA commissioner, as a result …
News
Pfizer logo

Pfizer wins Zoloft birth defects lawsuit

October 12, 2015 Sales and Marketing Pfizer, Zoloft, birth defects, lawsuits, sertraline

Judges in the US have dismissed a lawsuit against Pfizer that had claimed that the use of its antidepressant Zoloft during pregnancy …
News
keytruda3-web

MSD’s Keytruda receives green light from NICE for NHS use

October 12, 2015 Sales and Marketing MSD, Merck, NICE, keytruda, melanoma, pembrolizumab, skin cancer

The UK healthcare watchdog NICE has recommended Keytruda as a treatment for advanced skin cancer – its second endorsement of …
News
gsk_offices_in_rio_de_janeiro

How can pharma succeed in emerging markets?

October 10, 2015 Sales and Marketing GSK, Pfizer

In recent years, the major pharma companies have been forced to react to the maturation and cost-cutting, plus regulatory pressures, …
Feature
guido_rasi

EMA appoints Guido Rasi as executive director

October 9, 2015 Medical Communications, Sales and Marketing EMA, Guido Rasi

The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. The …
Appointment
money_pills

Oncology groups and doctors fight for lower-priced cancer treatments

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …
News
astrazeneca_plaque

AstraZeneca’s Moventig now available through NHS

October 9, 2015 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …
News
amerisourcebergen

AmerisourceBergen acquires sterile compounder PharMEDium for $2.5bn

October 7, 2015 Research and Development, Sales and Marketing AmerisourceBergen, mergers and acquisitions

AmerisourceBergen will now source compounded drugs for its hospital clients by manufacturing them itself after spending more than $2.5 billion …
News
joachim_hoeltz

Rondo AG appoints Joachim Hoeltz as chief exec

October 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Joachim Hoeltz has been appointed chief executive at pharmaceutical packaging company Rondo AG within the Business Area Medipak Systems. He …
Appointment
david-luther

David Luther joins MISSION Therapeutics

October 6, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing

Cambridge, UK-based MISSION Therapeutics has announced the appointment of David Luther as chief financial officer.Luther brings more than 25 years’ …
Appointment
cardinal_health

Cardinal Health completes $1.944bn acquisition of J&J’s Cordis

October 6, 2015 Manufacturing and Production, Sales and Marketing Cardinal Health, Cordis, mergers and acquisitions

Cardinal Health has completed the acquisition of Johnson & Johnson’s Cordis business: a global leader in cardiology and endovascular devices, …
News
teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015 Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026